The MAM-subfamily of type II transmembrane protein tyrosine phosphatases (PTPases) currently comprises the enzymes PTPk, PTPm and PCP2. In an effort to elucidate the individual physiological roles of these closely related proteins we performed a detailed analysis of their mRNA transcript distributions at different stages of mouse embryogenesis and postnatal brain development. Our in situ hybridization studies revealed distinct and complementary expression patterns of PTPk, PTPm and PCP2 transcripts. Based on our results and previous reports we discuss MAM-PTPases as a new class of morphoregulatory molecules.
Introduction
The development and morphogenesis of multicellular organisms as well as the maintenance of their integrity is based on the process of controlled cell proliferation, motility, adhesion and differentiation. The intricate and precise arrangements between many different cell types are achieved by a coordinated communication network that can either be mediated by soluble substances such as hormones, circulating growth factors and morphogens or by mechanisms that become operative in response to cell-cell or cell-substratum contact. Most cell surface molecules implicated in the interaction between adjacent cells or their extracellular matrix belong to the families of cadherins, selectins, integrins or immunoglobulins (Takeichi, 1990 (Takeichi, , 1991 Geiger and Ayalon, 1992; Hynes and Lander, 1992) .
The ability of cells to recognize one another, to assemble, and to adhere in a cell type specific manner has been detected in the vertebrate system as early as 1955 when Townes and Holtfreter (1955) demonstrated that epidermal precursor cells and neural plate-derived cells segregate from one another when mixed. This observation seemed to depend largely on intrinsic morphogenic capacities of individual cells. Different experimental approaches revealed that cadherins have such morphoregulatory properties and are involved in a number of morphogenic mechanisms including selective adhesion and cell sorting processes (reviewed in Takeichi, 1991) : for instance, cells that express different cadherins recognize and adhere to cells of their own subtype (Nose et al., 1988) but show only a very weak heterophilic interaction (Volk et al., 1987) with cells of a different type in co-culture or mixing experiments.
The classical cadherins comprise a growing family of at least a dozen members and are predominantly localized at cell adherens-type junctions (Takeichi, 1990; Suzuki et al., 1991) . Their extracellular domains promote homophilic, Ca 2+ -dependent interactions between adjacent cells, while the intracellular part of cadherins connects with structural components of the actin cytoskeleton via a family of molecules known as catenins (Ozawa et al., 1989; Ozawa and Kemler, 1992; Nagafuchi et al., 1993; Jou et al., 1995; Knudsen et al., 1995) . Each cadherin subtype is characterized by a unique spatial and temporal tissue distribution pattern during embryonic development and in adult organs, and cadherins have been identified in tissues derived from all germinal layers (Takeichi, 1988 (Takeichi, , 1995 Geiger and Ayalon, 1992; Kemler, 1992; Nakagawa and Takeichi, 1995) . In general, most types of cells express more than one subclass of cadherins. Their distribution and expression levels vary between cell types and the combinatorial action of multiple cadherins could be important in determining the selectivity of adhesion in vivo (Takeichi, 1991) .
Growing evidence now implicates tyrosine phosphorylation of the cadherin/catenin complex in the regulation of its function and adhesion properties. Growth factor stimulation or v-src tyrosine kinase overexpression induce enhanced tyrosine phosphorylation of both, N-and E-cadherin, as well as catenins. The phosphorylation is paralleled by a decrease in cell adhesion, loss of differentiation, increased migration, and the adoption of an invasive phenotype (Matsuyoshi et al., 1992; Behrens et al., 1993; Hamagushi et al., 1993; Shibamoto et al., 1994) . Moreover, EGF receptors were shown to be preferentially localized at cell boundaries in densely grown cell cultures (Lichtner and Schirrmacher, 1990) , and a direct association of b-catenin and g-catenin/ plakoglobin with the EGF receptor and HER2/c-erbB-2 has been reported (Hoschuetzky et al., 1994; Kanai et al., 1995; Ochiai et al., 1994) .
It therefore was of special interest to note that a number of transmembrane, receptor-like protein tyrosine phosphatases (PTPases) contain cell adhesion molecule-like motifs in their extracellular domains (Charbonneau and Tonks, 1992; Brady-Kalnay and Tonks, 1994) and could represent an additional link between cell adhesion and phosphotyrosine signalling. Some members of the type II family of transmembrane PTPases, namely PTPm (Gebbink et al., 1991) , PTPk (Jiang et al., 1993; Fuchs et al., 1996) and the recently identified human PCP2 (Wang et al., 1996) are composed of one so called MAM-domain (Beckmann and Bork, 1993) , one Ig-like domain and four fibronectintype III-like repeats in their extracellular part. Several lines of evidence suggest that type II PTPases and especially the MAM-subclass of this PTPase family, could play a role in the regulation of cell-cell adhesion: firstly, PTPm and PTPk have been shown to induce cell-cell aggregation in a homophilic manner (Brady-Kalnay et al., 1993; Gebbink et al., 1993; Sap et al., 1994) . The binding site that mediates this interaction was identified to reside in the Ig-like domain (Brady-Kalnay and Tonks, 1994) . Second, PTPm and PTPk expression levels drastically increase when cultured cells are grown to high density (Gebbink et al., 1996; Fuchs et al., 1996) , a phenomenon previously observed for the type III PTPase DEP-1 (Ö stman et al., 1994) . Moreover, PTPm, PTPk and PCP2 have been demonstrated to colocalize with the cadherin/catenin complex at sites of cell-cell contact (Brady-Kalnay et al., 1995; Gebbink et al., 1996; Fuchs et al., 1996; Wang et al., 1996) . A LAR-related member of type II PTPases has also been implicated in the regulation of cadherin function by its direct interaction with bcatenin (Kypta et al., 1996) . The recent finding that members of the cadherin/catenin complex associate with PTPm and PTPk in intact cells and are putative in vivo substrates for these PTPases (Brady-Kalnay et al., 1995; Fuchs et al., 1996) makes it tempting to assume a dual function for these molecules in contributing directly to the adhesion of cells by their extracellular domains and indirectly via regulation of the tyrosine phosphorylation balance at cell adherents junctions by their intracellular domains.
Based on these observations we were interested to identify possible physiological differences and specificities of the highly related MAM-PTPases PTPk, PTPm and PCP2. Northern blot analyses from adult tissue were performed and the distribution pattern of PTPm, PTPk, and PCP2 during late mouse development (days 12.5-18.5 p.c.) as well as in different stages of postnatal brain development was examined using the in situ hybridization technique. In order to perform these studies we cloned the murine cDNA homologue of human PCP2. We demonstrate here that PTPm, PTPk, and PCP2 are to a large extent differentially expressed during mouse embryogenesis and brain development. Together with previous observations our data suggest that these transmembrane MAM-PTPases may represent a new class of morphoregulatory molecules.
Results

Isolation of the full length murine PCP2 cDNA and a partial mPTPk cDNA
To perform a comparative in situ hybridization study of the three highly related MAM-domains containing type II PTPases identified so far, we cloned the murine homologue of human PCP2 (Wang et al., 1996) . cDNA libraries of mouse brain and placenta were screened with a full length human PCP2 probe under low stringency conditions. Out of 50 clones obtained and sequenced two clones were assembled to generate a full length coding region of 4311 bp with flanking 5′ and 3′ untranslated regions of 42 bp and 1041 bp, respectively. The predicted amino acid sequence of 1437 amino acids displayed 94 percent homology to the human PCP2 sequence. Fig. 1 shows the amino acid sequence of murine PCP2 and characteristic features of the phosphatase (the MAM-like domain, one Ig-like domain, four fibronectin (FN) type III-like domains and two conserved PTPase domains) are outlined. Interestingly, like the human counterpart, mouse PCP2 does not contain the processing motif recognized by subtilisin-like endoproteases within the fourth FN type III-domain that is present in PTPm and PTPk (Jiang et al., 1993; Brady-Kalnay et al., 1993; Gebbink et al., 1996; Fuchs et al., 1996) and other type II PTPases, for example LAR (Streuli et al., 1992; Yu et al., 1992) .
To obtain a fragment of mouse PTPk suitable for in situ hybridization a murine cDNA brain library was screened with a cDNA probe encoding the extracellular domain of human PTPk under low stringency conditions. Different clones were obtained and sequenced to confirm the identity of the respective mouse PTPk clones. One of the analysed clones with a length of 3072 bp revealed a divergent 3′-region (nucleotides 2596-3056) while retaining complete homology to mouse PTPk in the 5′-region (nucleotides [−] 182-2595; M. Fuchs and A. Ullrich, unpublished observations) . Translation into the putative amino acid sequence yielded a protein which lacked most of the intracellular domain compared to the full-length PTPk protein (Jiang et al., 1993) and we therefore termed it PTPk- [D] . We could subsequently confirm by the reverse transcription-polymerase chain reaction applying mRNA from different tissues that the alternatively spliced PTPk- [D] cDNA is specificially transcribed in mouse brain. The 1.3 kb N-terminal fragment used for the in situ hybridization studies presented in this work, however, completely matches the N-terminal region of the published sequence of mouse PTPk (Jiang et al., 1993) .
Comparative Northern blot analyses of MAM-PTPases
As a first step in our approach to elucidate similarities and differences in the expression pattern of PTPm, PTPk and PCP2 we analyzed different adult mouse tissues and mammary cell lines by Northern blot analysis. The radiolabeled PTPase fragments corresponded either to the extracellular part of mouse PTPk or mouse PTPm (nucleotides [−] 182-1971 and nucleotides 1-2368, respectively) or to a PCP2 fragment containing part of the extracellular domain and the whole intracellular domain (nucleotides 1600-3250).
Two PTPk transcripts of 5.3 and 7.0 kb could be detected at high levels in the brain, liver, kidney, intestine, placenta, skeletal muscle and heart and, at lower intensity, in the lung (Fig. 2, upper panel) . Interestingly, the tissue hybridization revealed the presence of an additional PTPk transcript of 4.2 kb specificially transcribed in brain which presumably represents the above mentioned putative alternatively spliced variant PTPk- [D] . Intensive signals of a size of 5.7 kb were detected in the brain, placenta, skeletal muscle and heart and, again at lower intensity, in the lung after hybridizing the Northern blot with a radiolabeled PTPm fragment. Liver, kidney, spleen, intestine, thyroid and testes showed only weak hybridization signals for PTPm (Fig. 2, second  panel) . Incubation of the filter with a radiolabeled PCP2-specific probe revealed strong hybridization signals only in brain and placenta, but no clear staining could be detected in any of the other tissues analyzed (Fig. 2, third panel) . This Northern blot analysis indicated a wide tissue distribution of PTPk and PTPm that, although quite similar, was distinctive with regard to the signal intensity detected in different organ systems. In contrast, PCP2 expression seems to be restricted in adult mouse tissue. An analysis of PTPase expression patterns in mouse mammary carcinoma cell lines, on the other hand, resulted in striking differences between PTPk and PTPm expression (data not shown). While PTPk transcripts were found with different signal intensities in most of the cell lines under study, PTPm transcripts were barely detectable in any of the cell lines. Similar results were obtained when different human mammary carcinoma cell lines were examined for PTPk and PTPm expression (data not shown).
In situ analysis of PTPk, PTPm and PCP2 mRNA expression
The distinct but overlapping expression patterns of the Fig. 1 . Predicted amino acid sequence of murine PCP2. The putative signal sequence is overlined, the MAM-domain is shaded, the Ig-like domain is indicated by a hatched overline, and the four fibronectin type III-like domains are indicated by overline brackets. The transmembrane domain is underlined and both PTPase domains are boxed.
three MAM-PTPases in the Northern blot analysis prompted us to investigate the spatial and temporal distribution pattern of PTPk, PTPm and PCP2 mRNA expression during mouse embryonic development. Our initial study of embryonic stages day 8.5 and 9.5 gave us weak and diffuse hybridization signals for PTPk and PTPm (data not shown) and we therefore decided to focus the analysis on later developmental stages. In the work shown here we used single-stranded antisense DNA probes containing either the extracellular domains of PTPk or PTPm (nucleotides [−] 182-1971 and nucleotides 1-2368, respectively) or applied a PCP2 antisense DNA probe containing a part of the extracellular and the whole intracellular domain (nucleotides 1600-3250). Cryosections of mouse embryos isolated on day 12.5, 14.5, 16.5 and 18.5 of development as well as mouse brains of newborn mice of postnatal days 2.5, 4.5 and 8.5 and adult mice were examined for each of the MAM-PTPases by in situ analysis.
Expression of PTPk during late mouse embryogenesis
Hybridization of serial sagittal cryosections of day 12.5, 14.5, 16.5 and 18.5 p.c. embryos with a specific probe revealed the presence of PTPk transcripts in a number of cell layers predominantly epithelial and neuronal in origin. In a day 12.5 p.c. embryo (Fig. 3B ) strong hybridization signals were detected in the olfactory epithelium which lines the nasal cavity and in the epithelial layers of the gut, the stomach (not shown) as well as the oropharynx (Fig. 3B ). An intense labeling could also be found in the pancreatic primordium, the cartilage primordium of the nasal bone and in the ventricular wall of the heart. A diffuse expression was detected in the lungs and the metanephros (not shown). In respect to neural tissue, PTPk transcripts were found in the neural tube and the basal plate of the grey matter, which is part of the mantle layer and corresponds to the ventral horn. A weaker silver label was also detected over the ependymal layer of the neural tube with some enhancement in the upper and lower plate. Analysis of the brain at day 12.5 of development revealed abundant transcripts of PTPk in the neuroepithelium of the telencephalon, the dorsal thalamus and the mesencephalon (Fig.  3B) .
In studies of embryonic day 14.5, expression of PTPk transcripts was more distinct but still involved the same organ systems. Prominent expression was found again in the epithelial layers of the stomach (Figs. 3E and 7E), the intestine and its physiological umbilical hernia ( Fig. 3E) as well as the intraperitoneal part of the midgut (Fig. 6A ). High expression levels also persisted in the primordium of the pancreas (Figs. 3E and 7C) . In the lungs the previously diffuse PTPk signal was now predominantly concentrated in the bronchial tree ( Fig. 3E) , and PTPk transcripts in the kidney were largely confined to glomerular structures of the medullar and cortical region (Figs. 3E and 6C) . PTPk specific labeling was also positive in the submandibular gland and the primordia of the follicles of the fibrissae. The periostal collars of the spinal column and the peritoneal linings of the abdominal cavity were also covered with silver label. The overall expression of PTPk had apparently increased with the development of the brain and exhibited a more distinct expression pattern of PTPk transcripts (Fig. 3E ).
Highly abundant hybridization signals were now obtained in the intermediate zone of the cerebral cortex and to a lower extent in the neocortical neuroepithelium and the subventricular zone, the primary and secondary germinal matrices, respectively (Fig. 3E ). They were absent, however, from the cortical plate of the cerebral cortex and the former dorsal telencephalon. Further expression was found in cells of the chorioid plexus, the neuroepithelium surrounding the fourth ventricle and in the inner ear. Some weak and diffuse silver 1-2368 or 1600-3250, respectively), washed and exposed for 14 days (PTPk and PTPm) on a X-ray film using an amplifying screen at −80°C. For PCP2, a phospho-image analysis using a Fuji X BAS 1000 apparatus is shown. To allow for comparison of equal RNA amounts loaded, the filter was rehybridized with a radiolabeled glycerine-aldehyde-3-phosphate dehydrogenase GAPDH- (Dugaczyk et al., 1983 ; fourth panel) and a bactin-(lower panel) specific probe. The positions of the 28S and 18S RNA are marked and the transcripts are indicated by arrowheads. (G) . Note the absence of specific silver label when parallel sections are hybridized with the respective control sense probe (C,F,I). Calibration bars indicate 1 mm. Abbreviations: na, nasal cavity; he, heart; li, liver; lu, lung; me, mesencephalon; ce, cerebellum; in, intestine; sto, stomach; sc, spinal cord; vi, vibrissae; sg, submandibular gland. *Indicates the pancreatic primordium in (B), the metencephalon in (E) or the enamel organ in (H). The arrows indicates the ventral horn (B), the cochlea (E) or the pituitary gland (H). (G) . Note the absence of specific silver label when parallel sections are hybridized with the respective control sense probe (C,F,I). Calibration bars indicate 1 mm. Abbreviations: th, thalamus; hy, hypothalamus; he, heart; li, liver; me, mesencephalon; in, intestine; sto, stomach; ki, kidney; lu, lung; cs, corpus striatum; ce, cerebellum; f, brown fat. *Indicates the neocortex (B), the metencephalon (E) or the dental papille (H), the arrows indicate the plexus choroideus (E) or the olfactory bulb (H). label could also be detected over the tegmentum and the meninges. The expression pattern of PTPk at day 16.5 p.c. was found to be similar to that of day 14.5 p.c. and it is not shown here.
Hybridization studies of sections of day 18 p.c. embryos demonstrated that PTPk expression was again very prominent in the epithelium lining the stomach and intestine (Fig.  3H ) and the rectum and the uterus (not shown). As seen in the earlier developmental stages the epithelium of the nasal cavity and septum and the serous nasal glands were weakly labeled. The PTPk transcript levels in the submandibular glands (Figs. 3H and 6F) had clearly increased in comparison to day 12.5 and 14.5. Silver labeling over the lungs now appeared to include broncheoli and alveolar structures and was no longer confined to the larger bronchi (Fig. 3H) . PTPk transcripts in the kidney persisted, but were now found to be concentrated in the cortex, where at this stage of embryonic development most glomerula are localized (not shown). The heart was again as in earlier stages an organ of intense PTPk-specific hybridization signals. Weak labeling could be observed in the enamel organ, a structure that belongs to the primordia of the incisor and molar teeth and derives from the oral epithelium. PTPk expression in the brain at this developmental stage was clearly confined to the cortical plate of the cerebral neocortex which increases in size during embryogenesis and is at this developmental stage the prominent part of the cerebral cortex. Weak PTPk transcripts in this layer have already been detected at embryonic day 16.5 p.c. (data not shown). PTPk expression in the subventricular zone, on the other hand, was found to be greatly reduced in comparison to earlier stages. Signals indicating PTPk transcripts were also obtained in the inferior colliculus of the midbrain, in some areas of the thalamus and hypothalamus, and were prominent in the pituitary gland. Examination of the spinal cord at days 16.5 and 18.5 p.c. revealed high PTPk expression in the dorsal and the ventral horn. This finding is in contrast to the distribution observed in the neural tube of the day 12.5 p.c. embryo where PTPk expression was restricted to the ventral portion.
This developmentally controlled expression pattern of PTPk during mouse emryogenesis indicates that a putative regulatory role of PTPk predominantly involves organs of epithelial origin and the developing brain.
Expression of PTPm during late mouse embryogenesis
In situ hybridization with a PTPm-specific antisensec DNA probe resulted in a speckled transcript distribution over the entire embryo at day 12.5 and 14.5 of development (Fig. 4B,E ). This striking pattern was caused by a very prominent transcription of PTPm in developing blood vessels. The specific PTPm expression in capillaries, arteries and venules gave rise to a vascular labeling pattern in virtually all major organs like the liver, intestine, stomach, mesenteric vessels, kidneys, adrenal glands, heart, lungs and the diaphragm. A very intense PTPm expression was also found in the embryonic brain where it was most prominent in the thalamus and hypothalamus at day 12.5 p.c. This cerebral expression pattern is, again, largely accounted for by PTPm transcripts in sprouting blood vessels (Fig. 4B) .
Examination of the brain at day 14.5 p.c. (Fig. 4E ) showed PTPm transcripts distributed throughout the neocortex and the corpus striatum, as well as in the choroid plexus and the meninges. Strong signals were also obtained in the inferior colliculus of the midbrain and in areas of the pons and medulla. The initial observation that PTPm expression is largely confined to developing blood vessels could not be confirmed in the brain at day 14.5 p.c. A comparison of parallel cryosections hybridized with either PTPm or flk-1, an endothelium specific protein tyrosine kinase (Millauer et al., 1993 ; see results below), showed that the cerebral expression of PTPm involves neuronal tissues as well.
Hybridization of cryosections of a day 18.5 p.c. embryo (Fig. 4H) clearly revealed that the ubiquitous vascular expression of PTPm had largely subsided. At this developmental stage intense labeling could still be detected in the heart, kidneys, the embryonic deposits of brown fat in the neck and with striking prominence in the lungs. In the latter PTPm expression was confined to the endothelial cells of capillaries and larger blood vessels but was completely absent from the epithelial lining in the bronchial tree (see enlargement, Fig. 5C ). High levels of PTPm transcripts were also found in the blood vessels of the submucosa of stomach and intestine and in the dental papilla of the developing tooth, another highly vascularized region at this stage of embryogenesis (Fig. 4H ). In the brain PTPm expression was greatly reduced in comparison to earlier developmental stages. Remaining silver label was largely confined to the olfactory bulb and the meninges. A highly demarcated expression of PTPm, however, was found in the cerebellum where it was strictly confined to the nascent Purkinje cell layer.
Comparison of PTPm and flk-1 expression
The expression pattern of PTPm during mouse embryonic development revealed to be largely restricted to the vasculature of all major organ systems. To determine whether PTPm labeling was exclusively and specifically restricted to developing blood vessels we compared the expression of PTPm with that of flk-1, a receptor tyrosine kinase that was shown before to be exclusively expressed in endothelial cells (Millauer et al., 1993) . Parallel parasagittal cryosections were hybridized with specific probes for either flk-1 or PTPm (Fig. 5) . A comparison of labeling patterns showed clearly that flk-1 and PTPm have a similar transcript distribution and therefore supports our interpretation that PTPm is predominantly expressed in endothelial cells. Both were detected in the meningeal layer, in the choroid plexus of the lateral ventricle and in blood vessels throughout the brain (Fig. 5A,B ; PTPm and flk-1, respectively). In a number of brain regions, however, the expression of PTPm was more extensive than that of flk-1 and not exclusively confined to the endothelium: PTPm transcripts were for example also expressed in the cerebral neuroepithelium, in the striatum, the posterior thalamus, and in the olfactory anlage (Fig. 5A) . No flk-1 transcripts could be detected in these regions (Fig.  5B) .
A comparison of PTPm and flk-1 expression in the abdominal cavity confirmed the close similarities between the two expression patterns. mRNA labeling for both molecules was found in all hepatic blood vessels and in the endothelial lining of the aorta, the vena cava, the mesenteric and umbilical vessels as well as in the blood vessels in the submucosa and muscularis underlying the intestinal epithelia ( Fig. 5D ,E; PTPm and flk-1 respectively). High magnification micrographs of the lung on day 18.5 p.c. show that PTPm transcripts are strictly confined to pulmonary capillaries and blood vessels and are not detectable in the epithelium of the bronchial tree (Fig. 5C ).
Differential in situ expression of PTPk and PTPm
For our comparative analysis of the expression pattern of PTPk and PTPm we used serial cryosections from the same embryo for in situ hybridizations. Although both PTPases are closely related and highly homologous their respective expression patterns during mouse embryonic development were not only unrelated but often mutually exclusive as exemplified in the panels in Figs. 6 and 7. Fig. 6A ,B present parasagittal sections through the midgut of a day 14.5 p.c. embryo at a higher magnification. While PTPk transcripts are restricted to the epithelium of the gut and do not extend to underlying cell layers (Fig. 6A) , PTPm expression is found in the submucosa and muscularis in which it is confined to small blood vessels and larger arteries but is absent from the epithelial layer (Fig. 6B) . A similar distribution was also found in the stomach (Fig. 7E,F) where PTPk transcripts were restricted to the epithelium (Fig. 7E ) and the speckled distribution of PTPm transcripts was again confined to the blood vessels in the submucosa and muscularis layers (Fig. 7F) . When glandular tissues were examined the labeling pattern of PTPk and PTPm was again mutually exclusive: in magnified micrographs of the submandibular gland at day 18.5 p.c. (Fig. 6E,F) or the pancreas at day 14.5 p.c. (Fig. 7C,D) , PTPk was found to be expressed in the acinar serous glands (Figs. 6F and 7C) whereas PTPm labeling was detected in the endothelial cells of capillaries and small blood vessels between the parenchyma (Figs. 6E and   7D ). A differential expression of PTPk and PTPm can also be demonstrated in the retina of the eye of a day 18.5 p.c. embryo (Fig. 7A,B) . While PTPk transcripts were detected in the marginal region of the outer nuclear layer of the neural retina (Fig. 7A) the PTPm transcripts predominated in the ganglionic layer (Fig. 7B) . Similarly, the expression of PTPk in the renal area was confined to the glomerula of the kidneys and the outermost cortex of the adrenals (Fig.  6C ) whereas signals indicating PTPm transcripts were strictly restricted to the renal and adrenal vasculature (Fig.  6D) . These data therefore indicate that, although PTPm and PTPk are closely related and largely homologous, their expression pattern during embryonic development is highly differential and appears to involve mutually exclusive anatomical and functional entities. While the extracranial areas of PTPk expression predominantly include tissues of epithelial origin, extracranial PTPm transcription is strictly and specifically confined to blood vessels of virtually all major organs.
Expression of PCP2 during late mouse embryogenesis
We have recently identified a new member of the MAMmotif containing type II PTPases termed PCP2 (pancreatic carcinoma phosphatase 2; Wang et al., 1996) . Because this novel PTPase is closely related to PTPk and PTPm we studied its in situ expression pattern to allow a comparison with PTPk and PTPm. Again we performed in situ hybridization studies on sagittal cryosections of mouse embryos isolated on day 12.5, 14.5, 16.5 and 18.5 of development. Only a limited expression of PCP2 was found in day 12.5 embryos with hybridization signals in the olfactory epithelium of the nasal cavity, the epithelium lining the oral cavity, the oropharynx and the intestine (Fig. 8B) . High PCP2 transcript levels were also detected in the upper and lower plate of the ependymal layer of the neural tube. In addition to a strong PCP2 label in the meninges, expression in the brain at this developmental stage was detected in the neuroepithelium of the cerebral cortex, in the subventricular zone of the pallidum, and in the posterior hypothalamus.
By far the most prominent abdominal expression of PCP2 transcripts in day 14.5 and day 16.5 of developing embryos was found in the glomeruli of the kidney (Fig. 8E,H) . Abundant PCP2-specific transcripts were further detected in primordia of the follicles of fibrissae and in the periostal collar of bone. Hybridization revealed a strikingly intense labeling in the eye of a day 14.5 p.c. embryo, where PCP2 transcripts were expressed in lens fibers and, to a lower extent, in the inner nuclear layer of the neuronal retina (Fig. 9A) . While the strong expression in the ocular lens persisted through all stages of development the PCP2 signal in the inner nuclear layer in the eye was found diminished at a day 18.5 p.c. embryo (not shown). The PCP2 labeling in the embryonic lungs, first detected on day 14.5 p.c. changed dynamically during development. While no PCP2 specific transcripts could be detected at embryonic day 12.5, a clearly visible signal was seen at day 14.5 p.c. that progressed to a very prominent expression at day 16.5 p.c., before returning to much lower intensities at embryonic day 18.5 (Fig. 8) . Similarly, the prominent PCP2 transcripts in the epithelial layers of the stomach and intestine at day 12.5 p.c. of development decreased significantly through day 14.5 p.c. (Fig. 8E) , to day 16.5 p.c. (Fig. 8H) , and were almost completely undetectable on day 18.5 p.c. (Fig. 8L) . Conversely, the intense label in the epithelial layers of the nasal cavity remained almost unchanged through these developmental stages up to day 18.5 p.c. (Figs. 8L and 9B ). Other tissues of epithelial origin like the oesophagus (Fig. 9C) and the cochlear duct of the inner ear (Fig. 9D) were also unaffected by changes in PCP2 expression. Strikingly prominent PCP2 specific hybridization signals were further detected in the enamel organ, an epidermal derivative contributing to the formation of the molar and incisor teeth (Figs. 8L and 9E) .
In situ hybridization of cryosections of the brain on day 14.5, 16.5 and 18.5 of development revealed that in the cerebral cortex PCP2 transcripts were primarily restricted to the neuroepithelium and the subventricular zone (Fig.  8D-K) . No PCP2 specific signals were detected in the intermediate zone where PTPk was found expressed at day 14.5 p.c. Very weak PCP2 transcript levels were detected in the cortical plate where we had not previously detected any PTPk expression at that stage. Additional PCP2 labeling was further observed in the hippocampus and a patchy silver label was found over the anterior hypothalamus and in the medulla. A very prominent hybridization label covered the meninges through all stages of development.
Taken together, during the late embryonic development of the mouse PCP2 mRNA transcripts are predominantly expressed in tissues of epithelial origin. The rapid but transient increase in pulmonary expression around day 16.5 p.c. and the progressive disappearance of the intestinal expression towards day 18.5 suggest that the temporal regulation of PCP2 transcription is more pronounced during embryogenesis than that of its close relatives PTPk and PTPm.
Comparison of PTPk, PTPm and PCP2 expression during postnatal brain development
The highly differential expression of PTPk, PTPm and PCP2 during embryonic brain development allow us to study the expression of these PTPases in the early postnatal and adult mouse brain. We therefore used the same in situ hybridization technique as above on a panel of sagittal and coronal cryosections of the brain on postnatal day 2.5, 4.5 and 6.5 and of the brain of adult animals but present only a few representative results. In coronal sections of the postnatal brain on day 4.5 PTPk transcripts were highly represented in the supragranular part of the cortical plate and the subplate of the central and cingulate neocortex as well as in the CA3 field of the hippocampus (Fig. 10A) . At lower levels of intensity PTPk labeling was found in the dentate gyrus of the hippocampus, in the periform cortex of the rhinencephalon and in different nuclei of the thalamus. Expression of PTPk RNA, however, was totally absent from the basal ganglia in all sections investigated. PTPm-specific label was predominantly found in the striatum (a basal ganglion composed of the nucleus caudatus and the putamen) but was absent from the pallidum (Fig.  10B) . Lower intensities of PTPm transcripts were further detected in the infragranular part of the cingulate and central neocortex, and a weak and diffuse expression was found in the thalamus and hypothalamus. PCP2 hybridization signals were revealed to be very prominent in the subicular area, and in the CA1 and CA2 field of the hippocampus. By comparison, PTPk labeling was much weaker (Fig. 10C) . In contrast to PTPk, PCP2 was completely absent from the CA3 field and from the gyrus dentatus. The lateral and medial habenular nuclei of the thalamus were strongly positive for PCP2 specific silver label, as was the cortical and lateral amygdaloid nucleus and the nuclei in the mediate thalamus. As seen with PTPm, low levels of PCP2 transcripts were present in the infragranular part of the cortical plate of the cingulate and, at even lesser intensity, in the central cortex and the amygdala.
The expression pattern in sagittal sections of adult brain closely resembled the pattern found at days 2.5, 4.5 and 6.5 of postnatal brain development. Fig. 11 represents comparative micrographs of serial cryosections of adult mouse brain hybridized with the specific probes for PTPk, PTPm and PCP2 (Fig. 10A,B,C, respectively) .
The most striking demonstration of the differential expression of PTPk, PTPm and PCP2 was found in the labeling pattern of the cerebellum of adult brain. While PTPk transcripts were exclusively found in the molecular layer (Figs. 11A and 12D) , PTPm was expressed exclusively and with high labeling intensity in the Purkinje cell layer (Figs. 11C and 12E ). PCP2 transcripts were exclusively found in the granular layer of the cerebellum (Figs. 11E  and 12F ). None of the three PTPases were detected in the white matter of the adult cerebellum. This distinct pattern, however, arose during different stages of embryonic brain development. PTPk expression was absent from the cerebellum during all embryonic stages analysed, whereas PTPm could be detected in Purkinje cells as early as this cell layer was formed (Fig. 4H) .
The transition from developing to mature cerebrum was not reflected equally in the change of PTPase expression. PCP2-specific transcripts could still be detected in the subventricular zone of the cerebral cortex and at high expression levels in the pontine gray nucleus and in the interpendicular nucleus of the midbrain (Fig. 11E) . Similarily, strong PTPk mRNA expression persisted in the cerebral cortex. The distribution of PTPk-, PTPm-and PCP2-specific signals in the hippocampus corresponded to the distribution at earlier embryonic stages. Highly abundant PCP2 hybridization signals were detected in the subicular area and the CA1 and CA2 fields of the hippocampus (Figs. 11A and  12C ). While PTPk transcripts were reduced in the latter region, they were increased in the CA3 field and the dentate gyrus (Figs. 11A and 12A ). PTPm specific labeling was nearly absent in the adult hippocampus ( Fig. 11; C1 ) but was found at strikingly high levels in the adult olfactory bulb, as already indicated by PTPm-specific hybridization signals in the embryo at day 18.5 p.c. (Fig. 4H) . Lower transcript levels in this organ could also observed for PTPk and PCP2. 
Discussion
Protein tyrosine phosphatases of the MAM-family, a subclass of type II transmembrane PTPases, have recently been implicated in the regulation of cell-cell adhesion processes. MAM-PTPases colocalize with members of the cadherin/ catenin family at the sites of cell-cell contacts (Brady-Kalnay et al., 1995; Gebbink et al., 1996; Fuchs et al., 1996; Wang et al., 1996) . An enzyme/substrate relationship for these molecules has been suggested based on the finding of a direct interaction between PTPm and PTPk with components of the cadherin/catenin complex and the capacity of PTPk to dephosphorylate b-catenin in vitro (Brady-Kalnay et al., 1995; Fuchs et al., 1996) . The term 'selective adhesion' which has been attributed to the family of classical cadherins, describes the mechanism by which cells expressing different cadherins sort out themselves to form separate cell populations (Nose et al., 1988; Takeichi, 1991) . Interestingly, a similar phenomenon of selective adhesion was also reported for PTPk and PTPm: mixed Sf9 cells expressing either PTPk or PTPm selectively form distinct sets of aggregates. This morphogenic capacity is based on the specificity of their MAM-domains (Zondag et al., 1995) . These observations led us to investigate the expression patterns of MAM-PTPases to reveal specific properties of these highlyrelated proteins.
We isolated the murine homologue of the previously identified MAM-PTPase PCP2 (Wang et al., 1996) in order to perform our in situ analysis. As expected, it displayed characteristic features that define the MAM-subfamily of type II PTPases including the MAM-domain, one Ig-like domain and four Fibronectin-type III domains. Most of the type II PTPases isolated so far contain a recognition sequence for subtilisin-like endoproteases within their extracellular domain inducing a posttranslational cleavage in two non-covalently linked subunits (Streuli et al., 1992; Yu et al., 1992) . A similar motif was not present in the human PCP2 sequence (Wang et al., 1996) and is also absent from the mouse homologue. However, the functional importance of this structural feature is currently still unclear.
Our in situ hybridization studies revealed that PTPk, PTPm and PCP2 are to a striking extent differentially and partly dynamically expressed during different stages of late mouse embryogenesis and postnatal murine brain development. The extracranial tissue distribution patterns for both PTPk-and PCP2-specific transcripts can be summarized as being predominantly epithelial but mutually exclusive. The PTPk gene, for example, was strongly transcribed in the epithelium lining the stomach and the intestine in all stages of embryonic development investigated as well as in glands like the pancreas and the submandibular gland. In contrast, PCP2 transcripts were absent from these glands and PCP2 gene expression gradually ceased in the intestine during embryogenesis. However, in the epithelium lining of the oesophagus or the cochlear duct of the inner ear intense PCP2-specific signals persisted throughout development. Similarily, PTPk transcripts were abundantly expressed in the heart, while PCP2 transcripts were absent from this organ. PTPm RNA messages are preferentially but not exclusively expressed in endothelial cells which we demonstrated by comparative analysis with the endothelial-specific receptor tyrosine kinase flk-1 (Millauer et al., 1993) . We also identified a similar differential expression pattern between the various MAM-PTPases in the brain as, for instance, demonstrated by the complementary expression in the adult cerebellum. However, there are also some locations in which PTPk and PCP2 expression appears not to be , PTPm (B,E) and PCP2 (C,F) specific mouse antisense probes. Abbreviations: dg, dentate gyrus; CA1-3, CA1-3 fields of the hippocampal formation; sm, stratum moleculare; Pu, Purkinje cell layer; sg, stratum granulare. mutually exclusive, at least during some developmental periods, for example in the glomeruli of the developing kidney, the nasal fibrissae or the lung primordia. The resolution of our in situ technique does not allow us to differ between single cell types and we can therefore not conclude whether an overlapping PTPk and PCP2 expression reflects simultaneous PTPase expression in one cell or is due to technical limitations.
The results of our in situ hybridization analyses are of particular interest with regard to a possible function of the MAM-PTPases in the regulation of the cadherin/catenin complex and therefore in cell adhesion processes during morphogenesis and development. Because tyrosine phosphorylation of the cadherin/catenin complex leads to a disintegration of junctional structures between neighbouring cells (Matsuyoshi et al., 1992; Behrens et al., 1993; Hamagushi et al., 1993; Shibamoto et al., 1994; Kinch et al., 1995) dephosphorylation of these complexes is presumably required for the formation of intact functional adherents junctions. Previous results suggested that the action of protein tyrosine phosphatases like PTPm and PTPk might mediate this dephosphorylation in vivo and therefore could support the formation and establishment of specific cell layers during morphogenesis. For this regulation to occur matching MAM-PTPases have to be expressed on neighbouring cells to allow homophilic interactions which are required for their stabilization at the sites of cell-cell contacts (Gebbink et al., 1996) . PTPm molecules, for example, are rapidly degraded unless they are 'trapped' at the sites of cell-cell contacts by their homophilic interactions (Gebbink et al., 1996) . The targeted localization of MAM-PTPases by their direct homophilic interaction could therefore allow them to interact with and dephosphorylate adjacent cadherin/catenin complexes. By this mechanism MAMPTPases might positively influence the stability of cellcell junctions. According to such a model, preformed cell layers expressing different MAM-PTPases would not be stabilized and as a consequence, cells with identical cadherins but different MAM-PTPases might tend to separate and to form stable cell layers consisting of cells expressing identical MAM-PTPases. The expression of MAM-PTPases with different interaction potentials could thus help to further define the selective adhesion of cells. Although the Northern blot analysis showed a partly overlapping expression of the different MAM-PTPases in various mouse organs our in situ analysis revealed a distinct and predominantly exclusive tissue distribution for PTPk, PTPm and PCP2 as would be expected for such a model. Consequently, one interpretation for this pattern could be the tendency of cells to preferentially assemble in cell layers expressing identical MAM-PTPases. MAM-PTPases could promote this morphogenetic process in two ways, first, by homophilic interactions of their extracellular domains and second, by stabilization of the intact cadherin/catenin complex by the action of their enzymatic properties. In this context, it will be of interest to investigate the behaviour of cells expressing identical cadherins but different MAM-PTPases in cell sorting experiments. The only weak and diffuse expression of these PTPases in early stages of development suggests that these proteins do not have a major cell sorting role in early morphogenic events during development but might mainly contribute to the formation and stabilization of tissue structures in later developmental stages.
We also mention the identification of an alternatively spliced PTPk version lacking both intracellular PTPase domains as well as the cadherin binding site. A possible function of such a protein could be to 'trap' PTPk molecules of adjacent cells at sites of cell-cell contacts by homophilic interaction without directly affecting the tyrosine content of the own cell while nevertheless stabilizing and 'activating' PTPk proteins on a neighbouring cell. The differences in the brain distribution pattern between these two alternative transcripts and the properties of this alternate PTPk protein will be a topic of further investigation.
The comparative expression analysis of the MAM-subfamily of type II PTPases presented here is an essential step towards the understanding of their biological function during development. Several observations suggested that these PTPases are involved in the regulation of cell-cell adhesion processes. Based on these previous reports and the differential expression of these MAM-PTPases during embryogenesis reported here, we suggest that these transmembrane polypeptides play a role in the formation of tissues and organs during development and thus may be regarded as a new class of morphoregulatory proteins.
Materials and methods
cDNA cloning of murine PCP2 and mouse PTPk
A full length human PCP2 probe was used for screening of mouse brain and placental cDNA libraries (Clontech) under low stringency conditions. A cDNA fragment corresponding to the extracellular domain of human PTPk was used to screen a brain cDNA library under low stringency conditions. DNA sequencing of the clones was performed with the dideoxynucleotide chain termination method (Sanger et al., 1977) using sequenase, reagents, and protocols supplied by the United States Biochemical Corporation.
RNA extraction and Northern blot analysis
RNA was extracted from different frozen mouse tissues according to the acidic phenol method of Chomczynski and Sacchi (1987) . Oligo(dT)-column chromatography was used for the selection of poly(A + )-RNA. Aliquots were separated on a 1.2% agarose formaldehyde gel (Sambrook et al., 1990 ) and transferred to a nylon membrane (Amersham). Hybridizations were performed overnight in 50% formamid, 5× standard saline citrate (SSC; 750 mM sodium chloride, 75 mM sodium citrat), 5× Denhardt's (0.1% Ficoll 400, 0.1% polyvinylpyrrolidone, 0.1% bovine serum albumin (BSA)) and 50 mM NaPO 4 (pH 6.8) at 42°C with 1-3 × 10 6 c.p.m./ml of [a-32 P]ATP random primed DNA probes, followed by high stringency washes in 0.2 × SSC, 0.2% sodium dodecyl sulfate at 50°C. Filters were exposed for 14 days using an amplifying screen at −80°C. For repeated use, the filter was stripped of labeled DNA by washing in distilled water at 95°C for 10 min.
Preparation of hybridization probes
For Northern blot hybridization, 5′-located fragments of PTPk (nucleotides [−]182-1971) and PTPm (nucleotides 1-2368) or a fragment containing an extracellular part as well as the whole intracellular region of PCP2 (nucleotides 1600-3250) were used, respectively. The indicated fragments were isolated and prepared for labeling with [a-32 P]dATP (Amersham) by random hexanucleotide priming (USB; Feinberg and Vogelstein, 1983) . The probes used for in situ hybridization analysis were subcloned into the pBluescript vector (Stratagene) using identical fragments as applied in Northern blot analysis. Single stranded DNA probes were prepared as described previously (Millauer et al., 1993) . Briefly, RNA transcripts were synthesized from the linearized plasmid using T3-or T7-RNA-polymerase (Boehringer) and the DNA was degraded using DNase (RNase-free preparation; Boehringer). The RNA transcripts were used for random-primed cDNA synthesis with [a-35 S]dATP (Amersham) by reverse transcription with MMLV Reverse Transcriptase (BRL), resulting in small cDNA transcripts with a size of about 100 bp. After hydrolysis of the RNA, the probe was purified by Sephadex-G50 column chromatography.
In situ hybridization
Balb/c mice were mated overnight and the morning of vaginal plug detection was defined as 0.5 days of gestation. For in situ hybridization embryos of various stages or brain isolated at different postnatal stages of mouse development or adult mice were embedded in Tissue-Tek (Miles), frozen on the surface of liquid nitrogen, and stored at −70°C prior to use. Sectioning, postfixation and hybridization were performed as described previously (Millauer et al., 1993) . Thick sections (10 mm) were incubated overnight with the [ 35 S]cDNA probe (final concentration 2 × 10 4 c.p.m./ml) at 52°C in a buffer containing 50% formamide, 300 mM NaCl, 10 mM Tris-HCl, 10 mM NaPO 4 (pH 6.8), 5 mM EDTA, 0.02% Ficoll 400, 0.02% Polyvinylpyrrolidone, 0.02% BSA, 10 mg/ml yeast RNA, 10% dextran sulfate, and 10 mM 1,4-dithiothreitol (DTT). Posthybridization washing was performed at high stringency (50% formamide, 300 mM NaCl, 10 mM Tris-HCl, 10 mM NaPO 4 (pH 6.8), 5 mM EDTA, 10 mM DTT at 52°C). Slides were coated with Kodak NTB2 film emulsion and exposed for approximately 21 days. All sections were analysed with an Olympus BH2 or SZ-PT microscope using brightfield and darkfield illumination.
